Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and evaluation of anticancer activity of new pyrazoline derivatives by down-regulation of VEGF: Molecular docking and apoptosis inducing activity
Rasha A. Hassan, Soha H. Emam, Dukhyun Hwang, et al.
Bioorganic Chemistry (2021) Vol. 118, pp. 105487-105487
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activities
Wael A.A. Fadaly, Mohamed T. M. Nemr, Nesma M. Kahk
Bioorganic Chemistry (2024) Vol. 147, pp. 107403-107403
Closed Access | Times Cited: 14
Thiazole-pyrazoline hybrids as potential antimicrobial agent: Synthesis, biological evaluation, molecular docking, DFT studies and POM analysis
Rezan Huseen Hama Salih, Aso Hameed Hasan, Narmin Hamaamin Hussen, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135191-135191
Closed Access | Times Cited: 36
Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies
Manish Rana, Md Imam Faizan, Sajad Hussain Dar, et al.
ACS Omega (2022) Vol. 7, Iss. 26, pp. 22639-22656
Open Access | Times Cited: 31
Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR‐2 and DNA gyrase inhibition, and in silico studies
Soha H. Emam, Rasha A. Hassan, Eman O. Osman, et al.
Drug Development Research (2023) Vol. 84, Iss. 3, pp. 475-499
Closed Access | Times Cited: 17
Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 6
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study
Wafaa A. Ewes, Samar S. Tawfik, Aya M. Almatary, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3186-3186
Open Access | Times Cited: 6
Synthetic aspects, structural insights and pharmacological potential of pyrazole derivatives: an overview
Regina Menezes, K. Subrahmanya Bhat
Deleted Journal (2025) Vol. 7, Iss. 2
Open Access
Density functional modeling, and molecular docking with SARS-CoV-2 spike protein (Wuhan) and omicron S protein (variant) studies of new heterocyclic compounds including a pyrazoline nucleus
Soner Akman, Senem Akkoç, Celal Tuğrul Zeyrek, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 12951-12965
Closed Access | Times Cited: 13
Design and synthesis of novel hexahydrobenzo[4,5]thieno[2,3‐d]pyrimidine derivatives as potential anticancer agents with antiangiogenic activity via VEGFR‐2 inhibition, and down‐regulation of PI3K/AKT/mTOR signaling pathway
Safaa E. Seif, Zeinab Mahmoud, Wagnat W. Wardakhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 839-860
Closed Access | Times Cited: 13
Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone‐based derivatives as DHFR inhibitors
Eman O. Osman, Soha H. Emam, Amr Sonousi, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 888-906
Closed Access | Times Cited: 13
Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking
Rasha A. Hassan, Maha M. Abdel‐Fattah, Amr M. Abdou, et al.
Bioorganic Chemistry (2022) Vol. 125, pp. 105861-105861
Open Access | Times Cited: 19
Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity
Amr Sonousi, Rasha A. Hassan, Eman O. Osman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2644-2659
Open Access | Times Cited: 17
New Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
Paweł Kozyra, Danuta Krasowska, Monika Pitucha
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6084-6084
Open Access | Times Cited: 16
Synthesis of Difluoromethyl Pyrazolines and Pyrazoles by [3+2] Cycloaddition Reaction of Difluoroacetohydrazonoyl Bromides with Electron‐deficient Olefins
Yuanyuan Ren, Ransong Ma, Yang Feng, et al.
Asian Journal of Organic Chemistry (2022) Vol. 11, Iss. 11
Closed Access | Times Cited: 15
Design, synthesis, anticancer evaluation, and in silico studies of some thieno[2,3‐d]pyrimidine derivatives as EGFR inhibitors
Menna Tallah M. Sayed, Peter A. Halim, Afaf K. El‐Ansary, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1299-1319
Closed Access | Times Cited: 8
Synthesis of ring fused difluoromethyl pyrazolines and pyrazoles by cycloaddition of difluoroacetohydrazonoyl bromides with cyclic α,β-Unsaturated carbonyl compounds
Yuanyuan Ren, Ransong Ma, Xiaoyong Li, et al.
Tetrahedron (2023) Vol. 149, pp. 133711-133711
Closed Access | Times Cited: 7
Antioxidant capacity and cytotoxic effect of an optimized extract of isabella grape (Vitis labrusca) on breast cancer cells
M. Daniela Vélez, María Alejandra Llano-Ramírez, Carolina Ramón, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16540-e16540
Open Access | Times Cited: 6
Mimicry of sorafenib: novel diarylureas as VEGFR2 inhibitors and apoptosis inducers in breast cancer
Magda M. F. Ismail, Ebtehal M. Husseiny, Mona H. Ibrahim
New Journal of Chemistry (2023) Vol. 47, Iss. 24, pp. 11565-11576
Closed Access | Times Cited: 6
Novel pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity
Ahmed M. Abdelhamed, Rasha A. Hassan, Hanan H. Kadry, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2640-2657
Open Access | Times Cited: 6
Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold—A Short Review of Most Recent Studies 2013–2022
Paweł Kozyra, Monika Pitucha
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8874-8874
Open Access | Times Cited: 9
Recent Advances in Nanocatalyzed One-Pot Sustainable Synthesis of Bioactive N, N-Heterocycles with Anticancer Activities: An Outlook of Medicinal Chemistry
Sasadhar Majhi
Current Topics in Medicinal Chemistry (2024) Vol. 25, Iss. 1, pp. 63-95
Closed Access | Times Cited: 1
Pyrazolines inhibiting the activity of the early growth response-1 DNA-binding domain
Hyuk Yoon, Dongsoo Koh, Yoongho Lim, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 113, pp. 129952-129952
Closed Access | Times Cited: 1
New S‐substituted‐3‐phenyltetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one scaffold with promising anticancer activity profile through the regulation and inhibition of mutated B‐RAF signaling pathway
Safaa E. Seif, Wagnat W. Wardakhan, Rasha A. Hassan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Open Access | Times Cited: 1
Carbothioamide Based Pyrazoline Derivative: Synthesis, Single Crystal Structure, DFT/TD-DFT, Hirshfeld Surface Analysis and Biological Studies
Manish Rana, Aysha Fatima, Nazia Siddiqui, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 7, pp. 6181-6201
Closed Access | Times Cited: 8
Emerging insights into pyrazoline motifs: A comprehensive exploration of biological mechanisms and prospects for future advancements
Hesham A. Abou‐Zied, Eman A. M. Beshr, Alaa M. Hayallah, et al.
Journal of Molecular Structure (2023) Vol. 1296, pp. 136807-136807
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top